| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 75961 |
1059189-65-9，m-PEG4-CH2-aldehyde |
99 |
wyh |
2024-12-23 |
| 75962 |
cas:886209-60-5，perfluorophenyl 2-(cyclooct-2-ynyloxy)acetate |
116 |
zyl |
2024-12-23 |
| 75963 |
DOOCCH2CH2COOD烷基链试剂 |
111 |
h |
2024-12-23 |
| 75964 |
cas:1092654-47-1，Azido-PEG3-CH2CO2-NHS |
92 |
wyh |
2024-12-23 |
| 75965 |
N-芴甲氧羰基-五聚乙二醇-乙酸，Fmoc-NH-PEG5-CH2COOH |
103 |
wyh |
2024-12-23 |
| 75966 |
cas:1232769-29-7，Mal-CO-PEG5-NHS ester |
133 |
zyl |
2024-12-23 |
| 75967 |
氨基-PEG4-丁酸，Amino-PEG4-(CH2)3CO2H |
110 |
wyh |
2024-12-23 |
| 75968 |
cas:1342211-31-7， MC-Val-Ala-OH |
95 |
zyl |
2024-12-23 |
| 75969 |
cas:150244‐18‐1，sulfo-LC-SPDP |
136 |
zyl |
2024-12-23 |
| 75970 |
Azido-PEG3-CH2CO2Me，叠氮-三聚乙二醇-CH2CO2甲基 |
186 |
wyh |
2024-12-23 |
| 75971 |
cas:663598-89-8，1-(4-((5-nitropyridin-2-yl)disulfanyl)butanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
120 |
zyl |
2024-12-23 |
| 75972 |
99mTc-HYNIC-PEG4-E[PEG4-c（RGDfk）]2(即99mTc-3PRGD2) |
178 |
wyh |
2024-12-23 |
| 75973 |
cas:121115-30-8 SPDP-sulfo 2,5-dioxo-1-(3-(pyridin-2-yldisulfanyl)propanoyloxy)pyrrolidine-3-sulfonic acid |
138 |
zyl |
2024-12-23 |
| 75974 |
MP-PEG8-Val-Ala-PAB-(imp)PBD的组成部分 |
134 |
wyh |
2024-12-23 |
| 75975 |
perfluorophenyl 3-(2-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)ethoxy)propanoate |
149 |
zyl |
2024-12-23 |
| 75976 |
MC-Val-Cit-PABC-BF211，抗体药物偶联物(ADCs) |
138 |
wyh |
2024-12-23 |
| 75977 |
2,3,4,5,6-pentafluorophenyl 3-[2-(2-{2-[(4-formylphenyl)formamido]ethoxy}ethoxy)ethoxy]propanoate |
91 |
zyl |
2024-12-23 |
| 75978 |
DOPG:DOPC Liposomes,磷脂酰甘油与磷脂酰胆碱脂质体 |
258 |
axc |
2024-12-23 |
| 75979 |
cas:1353012-00-6，perfluorophenyl 1-azido-3,6,9,12-tetraoxapentadecan-15-oate |
116 |
zyl |
2024-12-23 |
| 75980 |
1V209-PEG23-TA ， 4，7，10-三氧杂-1，13-十三烷二胺和α-甘露糖 |
162 |
wyh |
2024-12-23 |
| 75981 |
cas:943858-70-6，Azidobutyric acid NHS ester |
121 |
zyl |
2024-12-23 |
| 75982 |
DOPG Liposomes,磷脂酰甘油脂质体 |
117 |
axc |
2024-12-23 |
| 75983 |
(64)Cu-NOTA-PEG4-LLP2A的结构组成 |
93 |
wyh |
2024-12-23 |
| 75984 |
99mTc(CO)3-DPA-DBCO-PEG4-CTT-54的显像效果 |
150 |
wyh |
2024-12-23 |
| 75985 |
DOPS:DOPC Liposomes,磷脂酰丝氨酸与磷脂酰胆碱脂质体 |
297 |
axc |
2024-12-23 |
| 75986 |
2,5-dioxopyrrolidin-1-yl 11-oxo-4,7,13-trioxa-10-azahexadec-15-yn-1-oate |
117 |
zyl |
2024-12-23 |
| 75987 |
DOPC Liposomes,二油酰磷脂酰胆碱脂质体 |
175 |
axc |
2024-12-23 |
| 75988 |
DTPA(Gd)-PEG8-(FY)3的结构特点 |
111 |
wyh |
2024-12-23 |
| 75989 |
Fucα1-2Gal-O-(CH2)3-NH-CS-NH-Fluorescein |
114 |
h |
2024-12-23 |
| 75990 |
DSPC Liposomes,二硬脂酰磷脂酰胆碱脂质体 |
167 |
axc |
2024-12-23 |
| 75991 |
GlcNAcβ1-3Galβ1-4Glc-O-(CH2)3-NH-Lipoic |
126 |
h |
2024-12-23 |
| 75992 |
HSPC Liposomes,氢化大豆磷脂酰胆碱脂质体 |
302 |
axc |
2024-12-23 |
| 75993 |
cas:80307-12-6，GMBS，N-(4-马来酰亚胺丁酰基)琥珀酰亚胺 |
186 |
zyl |
2024-12-23 |
| 75994 |
DMPC Liposomes,二肉豆蔻酰磷脂酰胆碱脂质体 |
221 |
axc |
2024-12-23 |
| 75995 |
Galβ1-4GlcNAcβ1-3Gal-O-(CH2)3-NH-DBCO 含DBCO的核心2型丙糖(接头-DBCO A) |
151 |
h |
2024-12-23 |
| 75996 |
DSPC:Chol Liposomes,二硬脂酰磷脂酰胆碱-胆固醇脂质体 |
400 |
axc |
2024-12-23 |
| 75997 |
Galβ1-3GlcNAcβ1-3Gal-O-(CH2)3-NH-CS-NH-Fluorescein |
173 |
h |
2024-12-23 |
| 75998 |
HSPC:Chol Liposomes,磷脂酰丝氨酸-胆固醇脂质体 |
528 |
axc |
2024-12-23 |
| 75999 |
Glcα1-4[Glcα1-4]8Glc-O-(CH2)3-NH-CS-NH-Fluorescein |
128 |
h |
2024-12-23 |
| 76000 |
DMPC:Chol Liposomes,二肉豆蔻酰磷脂酰胆碱-胆固醇脂质体 |
155 |
axc |
2024-12-23 |
| 76001 |
C34-PEG4-Chol ，胆固醇标记LA HIV融合抑制剂 |
136 |
wyh |
2024-12-23 |
| 76002 |
具有游离末端胺的麦芽酮糖DP9(接头-NH2 A) |
204 |
h |
2024-12-23 |
| 76003 |
DOPC:DSPE-mPEG2000 Liposomes,二油酰磷脂酰胆碱-聚乙二醇化二硬脂酰磷脂酰乙醇胺脂质体 |
286 |
axc |
2024-12-23 |
| 76004 |
氨基聚乙二醇十一酰胺，PEG-NHCO(CH2)11-NH2 |
106 |
wyh |
2024-12-23 |
| 76005 |
R(OTf)2Sn(CH2)8Sn(OTf)2CH2SiMe3的化学结构 |
117 |
wyh |
2024-12-23 |
齐岳微信公众号
官方微信
库存查询